Biodesix Inc
NASDAQ:BDSX

Watchlist Manager
Biodesix Inc Logo
Biodesix Inc
NASDAQ:BDSX
Watchlist
Price: 1.48 USD 1.37% Market Closed
Market Cap: 215.3m USD
Have any thoughts about
Biodesix Inc?
Write Note

Biodesix Inc
Investor Relations

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The company is headquartered in Boulder, Colorado and currently employs 218 full-time employees. The company went IPO on 2020-10-28. The firm uses its artificial intelligence (AI) platform, Diagnostic Cortex, to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus on lung disease. In addition to its diagnostic tests, it provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development and commercialization of companion diagnostics. The firm offers blood-based lung cancer tests across the lung cancer continuum of care, including Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. The firm also offers three SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralization Antibody Test.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Scott Hutton
President, CEO & Director
No Bio Available
Ms. Robin Harper Cowie
CFO, Secretary & Treasurer
No Bio Available
Mr. Kieran O'Kane
Chief Commercial Officer
No Bio Available
Dr. Heinrich Röder
Founder & CTO
No Bio Available
Ms. Jessica Olbricht
Senior Director of Human Resources
No Bio Available
Dr. Gary Anthony Pestano Ph.D.
Chief Development Officer
No Bio Available
Ms. Bobbi Coffin
Chief Growth Officer
No Bio Available
Dr. Steven C. Springmeyer
Co-Chief Medical Officer
No Bio Available
Mr. Christopher Vazquez
VP & Controller
No Bio Available

Contacts

Address
COLORADO
Boulder
2970 Wilderness Place, Suite 100
Contacts
+13034170500.0
www.biodesix.com